Code | 5866D | ||||||||||
MA number | 07/0252/20-S | ||||||||||
Product Form: | sol inf 10x400 mg/100 ml (fľ.LDPE) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Fresenius Kabi s.r.o., Czechia | ||||||||||
Therapeutic Class: | 07 - ANALGETICA, ANTIPYRETICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 30 | ||||||||||
Container: | bottle LDPE | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(3) hybrid application |
MA issued: | 30.11.2020 |
Validity: | 30.11.2025 |
SPC: | SPC_Ibuprofen Kabi 400 mg_03.2024.pdf |
PIL: | PIL_Ibuprofen Kabi 400 mg_03.2024.pdf |
Safety feature | Yes |
Data update: | 03.12.2020 |